🇺🇸 FDA

Intelligence · Patent portfolio

Alnylam Netherlands Patents

Full USPTO pharma patent portfolio for Alnylam Netherlands — grant dates, expiration, and drug cross-links.

Patents
379
Expiring ≤24m
4

Quick answer

Alnylam Netherlands has 379 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.

Page 8 of 8

  1. US 7902168

    Compositions and methods for inhibiting expression of Nav1.8 gene

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7893224

    Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7888498

    Compositions and methods for inhibiting expression of IKK-B gene

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7875711

    Compositions and methods for inhibiting expression of XBP-1 gene

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7871985

    Compositions and methods for inhibiting expression of factor VII gene

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7868160

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7846907

    Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7846908

    RNAi modulation of TGF-beta and therapeutic uses thereof

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7829693

    Compositions and methods for inhibiting expression of a target gene

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7812150

    RNAi modulation of Aha and therapeutic uses thereof

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7790878

    RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7786290

    Double-stranded ribonucleic acid with increased effectiveness in an organism

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7772200

    iRNA agents targeted to the Rho-A gene

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7772387

    Oligonucleotides comprising a modified or non-natural nucleobase

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7763590

    Compositions and methods for inhibiting expression of a mutant gene

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7759320

    Compositions and methods for inhibiting expression of a gene from the Ebola

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7749978

    Compositions and methods for inhibiting expression of Huntingtin gene

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7745418

    Compositions and methods for inhibiting viral replication

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7745608

    Modified iRNA agents

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7737265

    RNAi modulation of HIF-1 and therapeutic uses thereof

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7723512

    Oligonucleotides comprising a non-phosphate backbone linkage

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7723317

    RNAi modulation of ApoB and uses thereof

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7718629

    Compositions and methods for inhibiting expression of Eg5 gene

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7691824

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7674779

    RNAi modulation of MLL-AF4 and uses thereof

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7674778

    Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7632932

    Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

    Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7626014

    Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

    Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7615618

    Oligonucleotides comprising a non-phosphate backbone linkage

    Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7605251

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7592322

    RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

    Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7582745

    Compositions and methods for inhibiting expression of Nav1.8 gene

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7582744

    Chemically modified oligonucleotides

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7579451

    Oligonucleotides comprising a modified or non-natural nucleobase

    Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7528118

    RNAi modulation of ApoB and uses thereof

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7517865

    RNAi modulation of RSV and therapeutic uses thereof

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7507809

    RNAi modulation of RSV and therapeutic uses thereof

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7473525

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7423142

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7361752

    RNAi modulation of MLL-AF4 and uses thereof

    Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7348314

    Compositions and methods for inhibiting viral replication

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7320965

    Compositions and methods for inhibiting expression of Huntingtin gene

    Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7196184

    Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Alnylam Netherlands have?

379 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Alnylam Netherlands patents expire?

4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.